
NASDAQConsumer DefensivePackaged Foods
最新資料
US$1.22
+US$0.08 · +7.02%
Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements. NAII also offers extensive strategic partnering support, which encompasses a broad spectrum of services. These include research and development (such as customized product formulation, scientific research, and proprietary ingredients), clinical studies, manufacturing, marketing assistance, adherence to international regulatory and labeling laws, global product registration, diverse packaging and labeling design, product testing, evaluation, and overall regulatory review. Furthermore, the company markets its own proprietary beta-alanine ingredient, available under the brand names CarnoSyn and SR CarnoSyn. NAII produces its supplements in various formats, including capsules, tablets, chewable wafers, and powders. Its private-label manufacturing clients primarily consist of companies distributing nutritional supplements through direct sales networks, direct-to-consumer e-commerce platforms, and traditional retail stores. Natural Alternatives International, Inc. was established in 1980 and is based in Carlsbad, California.
收盤時
US$1.22
+US$0.08 · +7.02%
盤後
US$1.22
US$0.00 · 0.00%
10月12日 下午7:30 ET
盤中時間採用ET。市場資料可能有所延遲。
Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements. NAII also offers extensive strategic partnering support, which encompasses a broad spectrum of services. These include research and development (such as customized product formulation, scientific research, and proprietary ingredients), clinical studies, manufacturing, marketing assistance, adherence to international regulatory and labeling laws, global product registration, diverse packaging and labeling design, product testing, evaluation, and overall regulatory review. Furthermore, the company markets its own proprietary beta-alanine ingredient, available under the brand names CarnoSyn and SR CarnoSyn. NAII produces its supplements in various formats, including capsules, tablets, chewable wafers, and powders. Its private-label manufacturing clients primarily consist of companies distributing nutritional supplements through direct sales networks, direct-to-consumer e-commerce platforms, and traditional retail stores. Natural Alternatives International, Inc. was established in 1980 and is based in Carlsbad, California.
日內區間
目前US$1.22
52週區間
目前US$1.22
盤中時間採用ET。市場資料可能有所延遲。
GoAI 評分
賣出
估值
47
合理估值
情緒
55
多空交錯
風險
57
風險偏高
動能
27
動能減弱
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements. NAII also offers extensive strategic partnering support, which encompasses a broad spectrum of services. These include research and development (such as customized product formulation, scientific research, and proprietary ingredients), clinical studies, manufacturing, marketing assistance, adherence to international regulatory and labeling laws, global product registration, diverse packaging and labeling design, product testing, evaluation, and overall regulatory review. Furthermore, the company markets its own proprietary beta-alanine ingredient, available under the brand names CarnoSyn and SR CarnoSyn. NAII produces its supplements in various formats, including capsules, tablets, chewable wafers, and powders. Its private-label manufacturing clients primarily consist of companies distributing nutritional supplements through direct sales networks, direct-to-consumer e-commerce platforms, and traditional retail stores. Natural Alternatives International, Inc. was established in 1980 and is based in Carlsbad, California.
日內區間
目前US$1.22
52週區間
目前US$1.22
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 1.41億 USD | 1.3億 USD | 1.14億 USD | 1.54億 USD | 1.71億 USD |
| 銷貨成本 | 1.34億 USD | 1.21億 USD | 1.07億 USD | 1.36億 USD | 1.4億 USD |
| 毛利 | 783.5萬 USD | 928.9萬 USD | 686.5萬 USD | 1815.8萬 USD | 3050.9萬 USD |
| 研究與開發 | 230萬 USD | 180萬 USD | 190萬 USD | 210萬 USD | 250萬 USD |
| 銷售、一般及管理費用 | 1729.6萬 USD | 1654.9萬 USD | 1539.9萬 USD | 1486.9萬 USD | 1695萬 USD |
| 營業費用 | 1689.6萬 USD | 1794.9萬 USD | 1539.9萬 USD | 1344.5萬 USD | 1683萬 USD |
| 利息收入 | 5萬 USD | 16.8萬 USD | 17.6萬 USD | 3.3萬 USD | — |
| 利息支出 | 118.6萬 USD | 91.5萬 USD | 36.1萬 USD | 45.1萬 USD | 8.3萬 USD |
| 折舊和攤銷 | 470.9萬 USD | 456萬 USD | 464.7萬 USD | 425萬 USD | 416.5萬 USD |
| 營業利益 | −906.1萬 USD | −866萬 USD | −853.4萬 USD | 471.3萬 USD | 1367.9萬 USD |
| 淨利 | −2069.5萬 USD | −1357.5萬 USD | −721.7萬 USD | 252.2萬 USD | 1071.2萬 USD |
公司資料更新於 2026年10月13日。
近期已公布業績
近期已公布業績
| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 1990年1月5日 | 1:50 | — | — |
已生效 1990年1月5日
1:50
報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI33.56萬0.00%2.3兆 USD0.03%US$381.57-0.10%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV15.85萬0.00%268.09億 USD0.33%US$37.98+0.08%
Vanguard Extended Market ETFVXF10.94萬0.00%954億 USD0.05%US$233.52-0.63%
U.S. Micro Cap Portfolio ETFDFMC7.52萬0.00%75.58億 USD0.43%US$57.70-0.20%
Dimensional - US Small Cap ETFDFAS4.75萬0.00%338.69億 USD0.31%US$78.17-0.23%
EA Bridgeway Omni Small-Cap Value ETFBSVO3萬—23.91億 USD0.45%US$28.50+0.46%
Dimensional - US Core Equity 2 ETFDFAC1.86萬0.00%885.96億 USD0.21%US$45.31-0.04%
U.S. Core Equity 1 Portfolio ETF Class SharesDCOR1.15萬0.00%455.91億 USD0.17%US$84.43-0.01%
Vanguard Morningstar Total Stock Market ETFVTI
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Extended Market ETFVXF
U.S. Micro Cap Portfolio ETFDFMC
Dimensional - US Small Cap ETFDFAS
EA Bridgeway Omni Small-Cap Value ETFBSVO
Dimensional - US Core Equity 2 ETFDFAC
U.S. Core Equity 1 Portfolio ETF Class SharesDCORAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。